Leukemia & Lymphoma Society Therapy Acceleration Program
1 round tracked since 12 June 2025.
- Rounds
- 1
- Led
- 0
- Capital in these rounds
- $19M
Rounds
- EnteromeClinical-stage biotech developing OncoMimics immunotherapies for cancer $19MVenture · 12 Jun
No round matches these filters.